SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF

The prognosis of breast cancer brain metastasis (BCBM) is extremely poor due to its resistance to conventional therapy. Elucidation of the molecular mechanisms of BCBM could contribute to the development of new therapeutic targets. In this study, we isolated RNA samples from primary breast cancer or...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Ther Oncolytics
Autori principali: Xiao, Weikai, Zheng, Shaoquan, Xie, Xinhua, Li, Xing, Zhang, Lijuan, Yang, Anli, Wang, Jian, Tang, Hailin, Xie, Xiaoming
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Gene & Cell Therapy 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163054/
https://ncbi.nlm.nih.gov/pubmed/32322668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.03.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi